Karius Raises $100M in Series C Funding Led by Khosla Ventures and 5AM Ventures to Expand Genomic Diagnostics in Infectious Disease
Amount Raised
$100 Million
Round Type
Series C
Redwood CityBiotechnologyHealth CareGeneticsHealth DiagnosticsInvestors
Description
Karius®, Inc. has secured $100 million in Series C funding co-led by Khosla Ventures and 5AM Ventures, along with other investors, to expand access to advanced genomic diagnostics in infectious disease and address the antimicrobial resistance crisis.
Quick answer
Karius® raised $100 Million in a Series C round, dated May 2, 2024. Investors: Waycross Ventures, Innovation Endeavors, Blue Water Life Sciences, HBM Healthcare Investments, General Catalyst, Softbank Vision Fund 2, Seventure Partners and Gilde Healthcare. Karius® is based in Redwood City, California, United States.
- How much did Karius® raise?
- Karius® raised $100 Million in a Series C round on May 2, 2024.
- Who invested in Karius®?
- Waycross Ventures, Innovation Endeavors, Blue Water Life Sciences, HBM Healthcare Investments, General Catalyst, Softbank Vision Fund 2, Seventure Partners and Gilde Healthcare are named as investors in this round.
- What does Karius® do?
- Karius®, Inc. is a world leader in genomic diagnostics for infectious disease, with a focus on extending access to advanced genomic diagnostics and addressing the antimicrobial resistance crisis.
- Where is Karius® based and how big is it?
- Karius® is based in Redwood City, California, United States.
- Who are the decision-makers at Karius®?
- Fundz holds 1 contact at Karius®. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Health Diagnostics around the same time
Companies in the same sectors as Karius® that raised within 45 days of this round, from Fundz verified event records.
- Insight Molecular Diagnostics Inc. raised $16M on April 11, 2024.
- Matter Bio raised $7M (Seed) on May 29, 2024.
- Bionano Genomics raised $20M on May 24, 2024.
- En Carta Diagnostics raised $1.6M (Pre-Seed) on May 22, 2024.
- Kate Therapeutics raised $22M on May 17, 2024.
- Cerenome, Inc. raised $18M (Post-IPO Equity) on May 6, 2024.
Who to call at Karius®, and when
A new round usually means Karius® is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Karius® raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Karius®, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Karius®. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Karius® raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Karius® raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.